These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 31370952)

  • 1. Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
    Malik A; Masson R; Singh S; Wu WC; Packer M; Pitt B; Waagstein F; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2019 Aug; 74(5):617-627. PubMed ID: 31370952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers.
    Lam PH; Bhyan P; Arundel C; Dooley DJ; Sheriff HM; Mohammed SF; Fonarow GC; Morgan CJ; Aronow WS; Allman RM; Waagstein F; Ahmed A
    Clin Cardiol; 2018 Mar; 41(3):406-412. PubMed ID: 29569405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin Use and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
    Qamer SZ; Malik A; Bayoumi E; Lam PH; Singh S; Packer M; Kanonidis IE; Morgan CJ; Abdelmawgoud A; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2019 Nov; 132(11):1311-1319. PubMed ID: 31150644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
    Lam PH; Dooley DJ; Deedwania P; Singh SN; Bhatt DL; Morgan CJ; Butler J; Mohammed SF; Wu WC; Panjrath G; Zile MR; White M; Arundel C; Love TE; Blackman MR; Allman RM; Aronow WS; Anker SD; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2017 Oct; 70(15):1861-1871. PubMed ID: 28982499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin Discontinuation in Patients With HFrEF on Beta-Blockers: Implication for Future 'Knock-Out Trials' in Heart Failure.
    Lam PH; Liu K; Ahmed AA; Butler J; Heidenreich PA; Anker MS; Faselis C; Deedwania P; Aronow WS; Kanonidis I; Masson R; Gill GS; Morgan CJ; Arundel C; Allman RM; Wu WC; Fonarow GC; Ahmed A
    Am J Med; 2024 Oct; ():. PubMed ID: 39424217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure.
    Ahmed A; Bourge RC; Fonarow GC; Patel K; Morgan CJ; Fleg JL; Aban IB; Love TE; Yancy CW; Deedwania P; van Veldhuisen DJ; Filippatos GS; Anker SD; Allman RM
    Am J Med; 2014 Jan; 127(1):61-70. PubMed ID: 24257326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone.
    Lam PH; Dooley DJ; Inampudi C; Arundel C; Fonarow GC; Butler J; Wu WC; Blackman MR; Anker MS; Deedwania P; White M; Prabhu SD; Morgan CJ; Love TE; Aronow WS; Allman RM; Ahmed A
    Int J Cardiol; 2017 Jan; 227():462-466. PubMed ID: 27866868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.
    Ambrosy AP; Bhatt AS; Stebbins AL; Wruck LM; Fudim M; Greene SJ; Kraus WE; O'Connor CM; Piña IL; Whellan DJ; Mentz RJ
    Am Heart J; 2018 May; 199():97-104. PubMed ID: 29754673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
    Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
    Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
    Tsimploulis A; Lam PH; Arundel C; Singh SN; Morgan CJ; Faselis C; Deedwania P; Butler J; Aronow WS; Yancy CW; Fonarow GC; Ahmed A
    JAMA Cardiol; 2018 Apr; 3(4):288-297. PubMed ID: 29450487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of digoxin and risk of death or readmission for heart failure and sinus rhythm: A nationwide propensity score matched study.
    Madelaire C; Schou M; Nelveg-Kristensen KE; Schmiegelow M; Torp-Pedersen C; Gustafsson F; Køber L; Gislason G
    Int J Cardiol; 2016 Oct; 221():944-50. PubMed ID: 27441473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure.
    Sheriff HM; Thogaripally MR; Panjrath G; Arundel C; Zeng Q; Fonarow GC; Butler J; Fletcher RD; Morgan C; Blackman MR; Deedwania P; Love TE; Aronow WS; Anker SD; Allman RM; Ahmed A
    J Am Med Dir Assoc; 2017 Sep; 18(9):761-765. PubMed ID: 28501416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
    Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
    Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease.
    Patel S; Lam PH; Kanonidis EI; Ahmed AA; Raman VK; Wu WC; Rossignol P; Arundel C; Faselis C; Kanonidis IE; Deedwania P; Allman RM; Sheikh FH; Fonarow GC; Pitt B; Ahmed A
    Am J Med; 2023 Jul; 136(7):677-686. PubMed ID: 37019372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
    Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
    Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
    Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
    Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone antagonists and outcomes in real-world older patients with heart failure and preserved ejection fraction.
    Patel K; Fonarow GC; Kitzman DW; Aban IB; Love TE; Allman RM; Gheorghiade M; Ahmed A
    JACC Heart Fail; 2013 Feb; 1(1):40-7. PubMed ID: 23814702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.